# GO_biological_process_0095

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `GO_biological_process`  
**Author expected answer:** **D** — antibiotic biosynthetic process

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MGPANSEGTMFDAFSREVGDYYDQANELLRAMFTDNVHYGYWPDPSSIDPLAEAGERMTEQLYERLDVSAGHKVLDVGCGVGKPAAWLARKTGATVKGANVSRNQLEVARDRVRSEGLEDRVSFDLADAMHLPYADDSFDRIWAIESMIHMPDRDQVMREMARVLRPGGRLAIADIVVRGTLDDVATAVVEGFCTLSTARSLEHIDNYPALVEKAGLDLLELTDVSEQTRPTGPAVLPAFDVLLPTLGEEGVAQSKKAWGDMFDLPQYGYVLLTAGKP

[Multiple Choices]
A. intracellular signal transduction
B. negative regulation of G1/S transition of mitotic cell cycle
C. heme catabolic process
D. antibiotic biosynthetic process
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Gene Ontology (GO) Biological Process Prediction, which is to predict the primary biological process a given protein participates in, as defined by the Gene Ontology (GO) 'Biological Process' branch. A biological process is a series of molecular events that accomplishes a larger biological program, such as cell division or signal transduction. Based on the provided protein sequence, you must select the option that best describes the overall biological objective to which the protein contributes.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The exact sequence matches the UniProt record for methyltransferase GfsG. The record describes it as required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence, supporting antibiotic biosynthesis. The annotation supports the key, though the author’s exact source snapshot is unknown.

Citations as saved: [C5](#evidence-c5), [H4](#evidence-h4), [H5](#evidence-h5).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> A soluble bacterial enzyme sequence and possible methyltransferase-like features might favor a metabolic role over cell-cycle regulation, but they do not establish antibiotic biosynthesis or distinguish it reliably from other metabolic processes.


**Missing item-specific fact**

> The protein’s identity as GfsG and its experimentally supported role in FD-891/FD-892 biosynthesis are not provided in the question.


**Reason**

> Selecting D requires the protein-specific pathway assignment; it cannot be derived meaningfully from the sequence and choices alone.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched-record functional evidence supports D; none of the other listed choices is supported by the supplied sequence alone.


### Important caveats

- Reviewer-only annotations support the expected answer but were absent from the evaluated model input.
- The exact data source snapshot used by the author is unknown.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "A soluble bacterial enzyme sequence and possible methyltransferase-like features might favor a metabolic role over cell-cycle regulation, but they do not establish antibiotic biosynthesis or distinguish it reliably from other metabolic processes.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein’s identity as GfsG and its experimentally supported role in FD-891/FD-892 biosynthesis are not provided in the question.",
    "reason": "Selecting D requires the protein-specific pathway assignment; it cannot be derived meaningfully from the sequence and choices alone."
  },
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "H4",
      "H5"
    ],
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record for methyltransferase GfsG. The record describes it as required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence, supporting antibiotic biosynthesis. The annotation supports the key, though the author’s exact source snapshot is unknown."
  },
  "important_caveats": [
    "Reviewer-only annotations support the expected answer but were absent from the evaluated model input.",
    "The exact data source snapshot used by the author is unknown."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-record functional evidence supports D; none of the other listed choices is supported by the supplied sequence alone."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The exact sequence matches the UniProt record for methyltransferase GfsG. The record describes it as required for synthesis of macrolide antibiotics FD-891 and FD-892, with cited experimental evidence, supporting antibiotic biosynthesis. The annotation supports the key, though the author’s exact source snapshot is unknown.",
    "evidence_ids": ["C5", "H4", "H5"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "A soluble bacterial enzyme sequence and possible methyltransferase-like features might favor a metabolic role over cell-cycle regulation, but they do not establish antibiotic biosynthesis or distinguish it reliably from other metabolic processes.",
    "missing_item_specific_fact": "The protein’s identity as GfsG and its experimentally supported role in FD-891/FD-892 biosynthesis are not provided in the question.",
    "reason": "Selecting D requires the protein-specific pathway assignment; it cannot be derived meaningfully from the sequence and choices alone."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched-record functional evidence supports D; none of the other listed choices is supported by the supplied sequence alone."
  },
  "important_caveats": [
    "Reviewer-only annotations support the expected answer but were absent from the evaluated model input.",
    "The exact data source snapshot used by the author is unknown."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry E0D208 (Methyltransferase GfsG, Streptomyces halstedii) is experimentally characterized (ECO:0000269, PubMed:26630077) as a methylase required for synthesis of 16-membered macrolide antibiotics FD-891 and FD-892. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' with experimental evidence. GO:0017000 (antibiotic biosynthetic process) is annotated (IEA via keyword, but underpinned by experimental pathway evidence). The sequence matches the benchmark input exactly (SHA-256 confirmed).

Citations as saved: [C5](#evidence-c5), [C6](#evidence-c6), [H4](#evidence-h4), [H5](#evidence-h5), [H6](#evidence-h6), [GO1](#evidence-go1).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a canonical SAM-dependent methyltransferase motif (VLDVGCGVGKP, Rossmann-fold class I MTase) and is a compact 278-aa protein. General biological knowledge allows: (1) eliminating B (G1/S mitotic regulation is strictly eukaryotic; the amino-acid composition—high Ala, Pro, Arg, Gly—indicates a high-GC bacterium, not a eukaryote); (2) eliminating C (heme catabolism proceeds via heme oxygenase ring-opening and biliverdin reductase, not SAM-dependent methylation); (3) distinguishing A from D: small standalone SAM-MTases (~250-350 aa) of this fold class are overwhelmingly characterized as tailoring enzymes in secondary-metabolite/antibiotic biosynthetic pathways in actinomycetes, whereas bacterial methyltransferases in signaling (e.g., CheR chemotaxis MTase) are substantially larger (~600 aa) and have distinct folds. Thus D is the most biologically coherent assignment among the four options.


**Missing item-specific fact**

> Confirmation that this specific methyltransferase methylates macrolide polyketide intermediates (rather than, say, a small-molecule signaling compound) is a protein-specific experimental finding. However, the general enzyme-class/size/organism reasoning sufficiently narrows the four options to make D the best-supported choice without requiring that exact fact.


**Reason**

> The sequence reveals enzyme class (SAM-MTase), approximate organism domain (bacterial, high-GC), and size (small tailoring enzyme). These general biological properties meaningfully distinguish D from the other three options through multi-step reasoning rather than requiring recall of a specific database annotation.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> B is eliminated as a eukaryotic mitotic process inconsistent with a bacterial protein. C is eliminated because heme catabolism does not involve SAM-dependent methyltransferases. A is disfavored because bacterial signaling methyltransferases (e.g., CheR) are much larger and structurally distinct from this small Rossmann-fold MTase. D is the single most defensible option given the enzyme class, size, and inferred organism.


### Important caveats

- The GO:0017000 annotation carries an IEA (Inferred from Electronic Annotation) evidence code via keyword, but the underlying PATHWAY comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).
- The organism (Streptomyces halstedii) is not provided in the model input; inference of bacterial origin relies on amino-acid composition heuristics.
- The reviewer-only evidence was absent from the evaluated model input; the reasoning argument uses only general biological knowledge applicable to the sequence and options.
- The distinction between A and D, while favoring D, is not airtight from sequence alone; a small SAM-MTase could in principle participate in a signaling methylation event, though this is far less common for proteins of this size and fold.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a canonical SAM-dependent methyltransferase motif (VLDVGCGVGKP, Rossmann-fold class I MTase) and is a compact 278-aa protein. General biological knowledge allows: (1) eliminating B (G1/S mitotic regulation is strictly eukaryotic; the amino-acid composition—high Ala, Pro, Arg, Gly—indicates a high-GC bacterium, not a eukaryote); (2) eliminating C (heme catabolism proceeds via heme oxygenase ring-opening and biliverdin reductase, not SAM-dependent methylation); (3) distinguishing A from D: small standalone SAM-MTases (~250-350 aa) of this fold class are overwhelmingly characterized as tailoring enzymes in secondary-metabolite/antibiotic biosynthetic pathways in actinomycetes, whereas bacterial methyltransferases in signaling (e.g., CheR chemotaxis MTase) are substantially larger (~600 aa) and have distinct folds. Thus D is the most biologically coherent assignment among the four options.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "Confirmation that this specific methyltransferase methylates macrolide polyketide intermediates (rather than, say, a small-molecule signaling compound) is a protein-specific experimental finding. However, the general enzyme-class/size/organism reasoning sufficiently narrows the four options to make D the best-supported choice without requiring that exact fact.",
    "reason": "The sequence reveals enzyme class (SAM-MTase), approximate organism domain (bacterial, high-GC), and size (small tailoring enzyme). These general biological properties meaningfully distinguish D from the other three options through multi-step reasoning rather than requiring recall of a specific database annotation."
  },
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "evidence_ids": [
      "C5",
      "C6",
      "H4",
      "H5",
      "H6",
      "GO1"
    ],
    "judgment": "supported",
    "reason": "UniProt entry E0D208 (Methyltransferase GfsG, Streptomyces halstedii) is experimentally characterized (ECO:0000269, PubMed:26630077) as a methylase required for synthesis of 16-membered macrolide antibiotics FD-891 and FD-892. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' with experimental evidence. GO:0017000 (antibiotic biosynthetic process) is annotated (IEA via keyword, but underpinned by experimental pathway evidence). The sequence matches the benchmark input exactly (SHA-256 confirmed)."
  },
  "important_caveats": [
    "The GO:0017000 annotation carries an IEA (Inferred from Electronic Annotation) evidence code via keyword, but the underlying PATHWAY comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).",
    "The organism (Streptomyces halstedii) is not provided in the model input; inference of bacterial origin relies on amino-acid composition heuristics.",
    "The reviewer-only evidence was absent from the evaluated model input; the reasoning argument uses only general biological knowledge applicable to the sequence and options.",
    "The distinction between A and D, while favoring D, is not airtight from sequence alone; a small SAM-MTase could in principle participate in a signaling methylation event, though this is far less common for proteins of this size and fold."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B is eliminated as a eukaryotic mitotic process inconsistent with a bacterial protein. C is eliminated because heme catabolism does not involve SAM-dependent methyltransferases. A is disfavored because bacterial signaling methyltransferases (e.g., CheR) are much larger and structurally distinct from this small Rossmann-fold MTase. D is the single most defensible option given the enzyme class, size, and inferred organism."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "GO_biological_process_0095",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry E0D208 (Methyltransferase GfsG, Streptomyces halstedii) is experimentally characterized (ECO:0000269, PubMed:26630077) as a methylase required for synthesis of 16-membered macrolide antibiotics FD-891 and FD-892. The PATHWAY comment explicitly states 'Antibiotic biosynthesis' with experimental evidence. GO:0017000 (antibiotic biosynthetic process) is annotated (IEA via keyword, but underpinned by experimental pathway evidence). The sequence matches the benchmark input exactly (SHA-256 confirmed).",
    "evidence_ids": ["C5", "C6", "H4", "H5", "H6", "GO1"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a canonical SAM-dependent methyltransferase motif (VLDVGCGVGKP, Rossmann-fold class I MTase) and is a compact 278-aa protein. General biological knowledge allows: (1) eliminating B (G1/S mitotic regulation is strictly eukaryotic; the amino-acid composition—high Ala, Pro, Arg, Gly—indicates a high-GC bacterium, not a eukaryote); (2) eliminating C (heme catabolism proceeds via heme oxygenase ring-opening and biliverdin reductase, not SAM-dependent methylation); (3) distinguishing A from D: small standalone SAM-MTases (~250-350 aa) of this fold class are overwhelmingly characterized as tailoring enzymes in secondary-metabolite/antibiotic biosynthetic pathways in actinomycetes, whereas bacterial methyltransferases in signaling (e.g., CheR chemotaxis MTase) are substantially larger (~600 aa) and have distinct folds. Thus D is the most biologically coherent assignment among the four options.",
    "missing_item_specific_fact": "Confirmation that this specific methyltransferase methylates macrolide polyketide intermediates (rather than, say, a small-molecule signaling compound) is a protein-specific experimental finding. However, the general enzyme-class/size/organism reasoning sufficiently narrows the four options to make D the best-supported choice without requiring that exact fact.",
    "reason": "The sequence reveals enzyme class (SAM-MTase), approximate organism domain (bacterial, high-GC), and size (small tailoring enzyme). These general biological properties meaningfully distinguish D from the other three options through multi-step reasoning rather than requiring recall of a specific database annotation."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "B is eliminated as a eukaryotic mitotic process inconsistent with a bacterial protein. C is eliminated because heme catabolism does not involve SAM-dependent methyltransferases. A is disfavored because bacterial signaling methyltransferases (e.g., CheR) are much larger and structurally distinct from this small Rossmann-fold MTase. D is the single most defensible option given the enzyme class, size, and inferred organism."
  },
  "important_caveats": [
    "The GO:0017000 annotation carries an IEA (Inferred from Electronic Annotation) evidence code via keyword, but the underlying PATHWAY comment is supported by experimental evidence (ECO:0000269, PubMed:26630077).",
    "The organism (Streptomyces halstedii) is not provided in the model input; inference of bacterial origin relies on amino-acid composition heuristics.",
    "The reviewer-only evidence was absent from the evaluated model input; the reasoning argument uses only general biological knowledge applicable to the sequence and options.",
    "The distinction between A and D, while favoring D, is not airtight from sequence alone; a small SAM-MTase could in principle participate in a signaling methylation event, though this is far less common for proteins of this size and fold."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `E0D208` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 28. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.
- Ontology names and EXACT synonyms match options mechanically; no answer-support judgment is made.
- Only is_a and part_of edges are used in supplied graph paths; all qualifiers and obsolete/replaced_by tags remain in literal source blocks.
- The ontology is newer than the benchmark repository commit; the exact author ontology snapshot is unknown.
- No matching term or path does not establish that an option is false.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)  
**Locator:** `/comments/0`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:56.118083+00:00.  

```json
{"commentType":"FUNCTION","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"20589823","source":"PubMed"},{"evidenceCode":"ECO:0000269","id":"26630077","source":"PubMed"}],"value":"Methylase required for synthesis of the 16-membered macrolide antibiotics FD-891 and FD-892 (PubMed:20589823, PubMed:26630077). In vitro uses S-adenosyl-L-methionine to methylate a number of biosynthetic intermediates in the synthesis of FD-891 (PubMed:26630077)"}]}
```

Source SHA-256: `85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0`.

### Evidence C6

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E0D208.json)  
**Locator:** `/comments/2`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:27:56.118083+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000269","id":"26630077","source":"PubMed"},{"evidenceCode":"ECO:0000305","id":"20589823","source":"PubMed"}],"value":"Antibiotic biosynthesis"}]}
```

Source SHA-256: `85a828a87c51921c250c7dfea7e360da93d816eafd568bf000dc2c70ce5c24c0`.

### Evidence H4

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)  
**Locator:** `lines 54-59`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 28 / 1.  
**Retrieved:** 2026-11-02T04:28:00.650050+00:00.  

```text
CC   -!- FUNCTION: Methylase required for synthesis of the 16-membered macrolide
CC       antibiotics FD-891 and FD-892 (PubMed:20589823, PubMed:26630077). In
CC       vitro uses S-adenosyl-L-methionine to methylate a number of
CC       biosynthetic intermediates in the synthesis of FD-891
CC       (PubMed:26630077). {ECO:0000269|PubMed:20589823,
CC       ECO:0000269|PubMed:26630077}.
```

Source SHA-256: `b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef`.

### Evidence H5

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)  
**Locator:** `lines 66-67`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 28 / 1.  
**Retrieved:** 2026-11-02T04:28:00.650050+00:00.  

```text
CC   -!- PATHWAY: Antibiotic biosynthesis. {ECO:0000269|PubMed:26630077,
CC       ECO:0000305|PubMed:20589823}.
```

Source SHA-256: `b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef`.

### Evidence H6

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E0D208?format=txt&versions=28)  
**Locator:** `lines 88-88`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 28 / 1.  
**Retrieved:** 2026-11-02T04:28:00.650050+00:00.  

```text
DR   GO; GO:0017000; P:antibiotic biosynthetic process; IEA:UniProtKB-KW.
```

Source SHA-256: `b7192a0f66b33ae1c0454812f81ce6522ffac94ec64111595e98e4c543e8a6ef`.

### Evidence GO1

[Gene Ontology current ontology](https://current.geneontology.org/ontology/go-basic.obo)  
**Locator:** `lines 132339-132351`  
**Scope:** current ontology; exact historical benchmark ontology unknown.  
**Retrieved:** 2026-11-01T07:04:24.975173+00:00.  

```text
[Term]
id: GO:0017000
name: antibiotic biosynthetic process
namespace: biological_process
def: "The chemical reactions and pathways resulting in the formation of an antibiotic, a substance produced by or derived from certain fungi, bacteria, and other organisms, that can destroy or inhibit the growth of other microorganisms." [GOC:curators]
subset: goslim_metagenomics
synonym: "antibiotic anabolism" EXACT []
synonym: "antibiotic biosynthesis" EXACT []
synonym: "antibiotic formation" EXACT []
synonym: "antibiotic synthesis" EXACT []
is_a: GO:0009058 ! biosynthetic process
is_a: GO:0016999 ! antibiotic metabolic process

```

Source SHA-256: `b08d45b268b8c24ccb2513dbbbc7d4df9f6521c099b413f79eb31e06e0fa3bcc`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/GO_biological_process.json), zero-based source row 95. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
